JPMorgan Chase & Co. (JPM), Wells Fargo & Co (WFC): Bank of America Corp (BAC)’s Legal Liability Is About to Soar

Page 1 of 2

There is little doubt that it is a positive move for Bank of America Corp (NYSE:BAC) to bring Merrill Lynch into the family fold, a merger that will save money and break down the wall that still seems to exist between the two.

As B of A absorbs Merrill’s assets and liabilities, however, investors should be aware that the latter is substantial, particularly in one area: representations and warranties concerning past sales of mortgage-backed securities, claims against which are cropping up more often lately.

Bank of America Corp (NYSE:BAC)

Lawsuits are piling up

Merrill’s 10Q form lays out the problems it faces from unresolved reps and warranty claims against MBSes it sold in the 2000s. As of June 30 of this year, Merrill’s estimated liability for unresolved repurchase claims from private investors was $7.2 billion. Adding in claims from monoline insurers and Fannie Mae and Freddie Mac bumps the number up to $7.4 billion. Merrill notes that another $1.2 billion in claims stem from a servicer Merrill believes has no valid claim.

That’s quite a bit — and it looks like it could get worse. As of December 2012, Merrill’s liability in this area stood at only $5.8 billion. The bank notes that it expects these private-label claims to increase, as well.

At minimum, it seems, Bank of America Corp (NYSE:BAC) can expect to immediately add another $7.4 billion to its MBS liability levels once Merrill Lynch is fully integrated. That’s on top of B of A’s own stated $16.6 billion in liability, which, at least, dropped from $28.3 billion at the end of 2012. Similar to Merrill, however, Bank of America notes some additional claims of $1.5 billion, which the bank claims have no merit.

MBS woes are widespread for big banks

This problem is not limited to Merrill and B of A, though Countrywide has added a layer of mortgage-based turmoil to the latter that other banks haven’t experienced. Still, peers JPMorgan Chase & Co. (NYSE:JPM) and Wells Fargo & Co (NYSE:WFC) haven’t escaped the ire of investors, mortgage insurers, or government-sponsored entities, either. At a mere $2.2 billion estimated liability for unresolved claims at the end of June 2013, Wells Fargo & Co (NYSE:WFC) is easily dwarfed by B of A, as is JPMorgan Chase & Co. (NYSE:JPM), which declared a comparable amount of $2.4 billion at the end of June. For Wells Fargo & Co (NYSE:WFC), management attributes its low liability to the fact that the bank has stayed away from the subprime mortgage market, though it admits that originations dated from 2006 to 2007 are still considered high-risk.

For JPMorgan Chase & Co. (NYSE:JPM), however, private-label repurchase liabilities are not folded in to that number, and the bank estimates that the total value of the securities involved in various lawsuits filed by private investors total $166 billion – which means its liability will likely be much higher than just $2.4 billion.

Bank of New York Mellon settlement: Still up in the air

The biggest wild card for Bank of America Corp (NYSE:BAC) remains the Blackrock New York Municipal Income Trst (NYSE:BNY) case. This settlement between B of A and 22 institutional investors regarding a slew of Countrywide MBSes gone bad is being reviewed by the New York Supreme Court, which is scrutinizing whether or not trustee Blackrock New York Municipal Income Trst (NYSE:BNY) Mellon acted “reasonably” under New York’s Article 77 law governing such settlements.

If the court decides BNY did not fulfill its responsibilities toward the investors, the entire $8.5 billion settlement, forged in 2011, could be thrown out. That would put Bank of America Corp (NYSE:BAC) in the precarious position of possibly paying quite a lot more to settle the case than it had originally planned.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!